Dianthus Therapeutics (DNTH) Liabilities and Shareholders Equity (2017 - 2025)
Dianthus Therapeutics (DNTH) reported Liabilities and Shareholders Equity of $530.92 million for Q4 2025, up 42.0% from $374.01 million a year earlier but down 8.1% from the prior quarter.
Dianthus Therapeutics (DNTH) Liabilities and Shareholders Equity (2017 - 2025) Analysis & Trends
Dating back to Q4 2017, Dianthus Therapeutics' Liabilities and Shareholders Equity record includes 32 quarters.
- Liabilities and Shareholders Equity has increased for three consecutive years, with a five-year compound annual growth rate of 26.9% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $374.01 million in FY2024 (+108.5%), $179.41 million in FY2023 (+115.9%), $83.11 million in FY2022 (-56.2%) and $189.93 million in FY2021 (+17.5%).
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $78.64 million in Q2 2023 and a high of $577.45 million in Q3 2025.
- Year over year, Liabilities and Shareholders Equity gained in six of the last eight quarters, with growth averaging 125.6%.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q2 2024 (growth of 369.2%); the low point was Q1 2023 (a decline of 57.1%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $577.45 million (Q3 2025), $326.08 million (Q2 2025) and $348.58 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Dianthus Therapeutics | 3.77 Bn | 3.72 Bn | - | 530.92 Mn |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 530.92 Mn |
| Sep 30, 2025 | 577.45 Mn |
| Jun 30, 2025 | 326.08 Mn |
| Mar 31, 2025 | 348.58 Mn |
| Dec 31, 2024 | 374.01 Mn |
| Sep 30, 2024 | 354.25 Mn |
| Jun 30, 2024 | 368.96 Mn |
| Mar 31, 2024 | 382.46 Mn |
| Dec 31, 2023 | 179.41 Mn |
| Sep 30, 2023 | 192.46 Mn |
| Jun 30, 2023 | 78.64 Mn |
| Mar 31, 2023 | 83.44 Mn |
| Dec 31, 2022 | 83.11 Mn |
| Sep 30, 2022 | 164.12 Mn |
| Jun 30, 2022 | 175.12 Mn |
| Mar 31, 2022 | 194.39 Mn |
| Dec 31, 2021 | 189.93 Mn |
| Sep 30, 2021 | 206.24 Mn |
| Jun 30, 2021 | 220.38 Mn |
| Mar 31, 2021 | 144.62 Mn |
Dianthus Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=DNTH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();